Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Genet Med ; 26(6): 101104, 2024 06.
Article in English | MEDLINE | ID: mdl-38411040

ABSTRACT

PURPOSE: The functionality of many cellular proteins depends on cofactors; yet, they have only been implicated in a minority of Mendelian diseases. Here, we describe the first 2 inherited disorders of the cytosolic iron-sulfur protein assembly system. METHODS: Genetic testing via genome sequencing was applied to identify the underlying disease cause in 3 patients with microcephaly, congenital brain malformations, progressive developmental and neurologic impairments, recurrent infections, and a fatal outcome. Studies in patient-derived skin fibroblasts and zebrafish models were performed to investigate the biochemical and cellular consequences. RESULTS: Metabolic analysis showed elevated uracil and thymine levels in body fluids but no pathogenic variants in DPYD, encoding dihydropyrimidine dehydrogenase. Genome sequencing identified compound heterozygosity in 2 patients for missense variants in CIAO1, encoding cytosolic iron-sulfur assembly component 1, and homozygosity for an in-frame 3-nucleotide deletion in MMS19, encoding the MMS19 homolog, cytosolic iron-sulfur assembly component, in the third patient. Profound alterations in the proteome, metabolome, and lipidome were observed in patient-derived fibroblasts. We confirmed the detrimental effect of deficiencies in CIAO1 and MMS19 in zebrafish models. CONCLUSION: A general failure of cytosolic and nuclear iron-sulfur protein maturation caused pleiotropic effects. The critical function of the cytosolic iron-sulfur protein assembly machinery for antiviral host defense may well explain the recurrent severe infections occurring in our patients.


Subject(s)
Iron-Sulfur Proteins , Zebrafish , Animals , Humans , Iron-Sulfur Proteins/genetics , Iron-Sulfur Proteins/metabolism , Male , Female , Phenotype , Fibroblasts/metabolism , Fibroblasts/pathology , Cytosol/metabolism , Neurodegenerative Diseases/genetics , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/pathology , Microcephaly/genetics , Microcephaly/pathology , Infant , Metallochaperones
2.
Pediatr Rev ; 42(3): 161-163, 2021 03.
Article in English | MEDLINE | ID: mdl-33648997
3.
Eur J Hum Genet ; 28(6): 770-782, 2020 06.
Article in English | MEDLINE | ID: mdl-32005960

ABSTRACT

TBR1, a T-box transcription factor expressed in the cerebral cortex, regulates the expression of several candidate genes for autism spectrum disorders (ASD). Although TBR1 has been reported as a high-confidence risk gene for ASD and intellectual disability (ID) in functional and clinical reports since 2011, TBR1 has only recently been recorded as a human disease gene in the OMIM database. Currently, the neurodevelopmental disorders and structural brain anomalies associated with TBR1 variants are not well characterized. Through international data sharing, we collected data from 25 unreported individuals and compared them with data from the literature. We evaluated structural brain anomalies in seven individuals by analysis of MRI images, and compared these with anomalies observed in TBR1 mutant mice. The phenotype included ID in all individuals, associated to autistic traits in 76% of them. No recognizable facial phenotype could be identified. MRI analysis revealed a reduction of the anterior commissure and suggested new features including dysplastic hippocampus and subtle neocortical dysgenesis. This report supports the role of TBR1 in ID associated with autistic traits and suggests new structural brain malformations in humans. We hope this work will help geneticists to interpret TBR1 variants and diagnose ASD probands.


Subject(s)
Autistic Disorder/genetics , Craniofacial Abnormalities/genetics , Intellectual Disability/genetics , Phenotype , T-Box Domain Proteins/genetics , Adolescent , Adult , Animals , Autistic Disorder/pathology , Child , Child, Preschool , Cognition , Craniofacial Abnormalities/pathology , Female , Hippocampus/diagnostic imaging , Hippocampus/pathology , Humans , Intellectual Disability/pathology , Male , Mice , Mutation , Neocortex/diagnostic imaging , Neocortex/pathology , Syndrome , T-Box Domain Proteins/metabolism
4.
J Clin Apher ; 27(4): 212-4, 2012.
Article in English | MEDLINE | ID: mdl-22307916

ABSTRACT

Streptococcus pneumoniae-associated hemolytic uremic syndrome (pHUS) is an atypical form of HUS associated with microangiopathic hemolytic anemia, thrombocytopenia and acute renal failure. Although less common than diarrhea-associated HUS, incidence appears to be increasing. We report a case of a child with pHUS who underwent a course of therapeutic plasma exchange (TPE) and had complete recovery. This report adds to the existing literature supporting TPE in cases of pHUS.


Subject(s)
Hemolytic-Uremic Syndrome/etiology , Hemolytic-Uremic Syndrome/therapy , Plasma Exchange , Pneumococcal Infections/complications , Atypical Hemolytic Uremic Syndrome , Child, Preschool , Female , Hemolytic-Uremic Syndrome/blood , Humans , Platelet Count , Treatment Outcome
5.
Hum Genet ; 131(1): 145-56, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21800092

ABSTRACT

Microdeletions of 1q43q44 result in a recognizable clinical disorder characterized by moderate to severe intellectual disability (ID) with limited or no expressive speech, characteristic facial features, hand and foot anomalies, microcephaly (MIC), abnormalities (agenesis/hypogenesis) of the corpus callosum (ACC), and seizures (SZR). Critical regions have been proposed for some of the more prominent features of this disorder such as MIC and ACC, yet conflicting data have prevented precise determination of the causative genes. In this study, the largest of pure interstitial and terminal deletions of 1q43q44 to date, we characterized 22 individuals by high-resolution oligonucleotide microarray-based comparative genomic hybridization. We propose critical regions and candidate genes for the MIC, ACC, and SZR phenotypes associated with this microdeletion syndrome. Three cases with MIC had small overlapping or intragenic deletions of AKT3, an isoform of the protein kinase B family. The deletion of only AKT3 in two cases implicates haploinsufficiency of this gene in the MIC phenotype. Likewise, based on the smallest region of overlap among the affected individuals, we suggest a critical region for ACC that contains ZNF238, a transcriptional and chromatin regulator highly expressed in the developing and adult brain. Finally, we describe a critical region for the SZR phenotype which contains three genes (FAM36A, C1ORF199, and HNRNPU). Although ~90% of cases in this study and in the literature fit these proposed models, the existence of phenotypic variability suggests other mechanisms such as variable expressivity, incomplete penetrance, position effects, or multigenic factors could account for additional complexity in some cases.


Subject(s)
Agenesis of Corpus Callosum/genetics , Chromosome Deletion , Chromosomes, Human, Pair 1/genetics , Genes/physiology , Microcephaly/genetics , Seizures/genetics , Abnormalities, Multiple , Adolescent , Agenesis of Corpus Callosum/pathology , Biomarkers/metabolism , Child , Child, Preschool , Comparative Genomic Hybridization , Female , Humans , In Situ Hybridization, Fluorescence , Infant , Intellectual Disability/genetics , Male , Microcephaly/pathology , Oligonucleotide Array Sequence Analysis , Phenotype , Seizures/pathology , Syndrome
6.
Pediatr Dermatol ; 27(2): 209-11, 2010.
Article in English | MEDLINE | ID: mdl-20537083

ABSTRACT

Granular cell tumors are benign neurally derived neoplasms, involving cutaneous and subcutaneous tissues; and typically occur as solitary lesions. Multiple granular cell tumors occur in 10% of affected individuals, but are in children. Children with underlying somatic and genetic syndromes, including neurofibromatosis and Noonan syndrome, appear to be at higher risk of developing multiple granular cell tumors. Skin biopsy assists in diagnosis, since granular cell tumors have a similar appearance to other cutaneous nodules. Painful or rapidly growing granular cell tumors should be excised and asymptomatic non-growing granular cell tumors may be observed. Children with multiple granular cell tumors should have a complete physical examination to rule out an underlying genetic syndrome.


Subject(s)
Granular Cell Tumor/diagnosis , Neoplasms, Multiple Primary/diagnosis , Noonan Syndrome/diagnosis , Skin Neoplasms/diagnosis , Child , Female , Granular Cell Tumor/genetics , Granular Cell Tumor/pathology , Granular Cell Tumor/surgery , Humans , Neoplasms, Multiple Primary/genetics , Neoplasms, Multiple Primary/pathology , Neoplasms, Multiple Primary/surgery , Noonan Syndrome/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics , Skin Neoplasms/genetics , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Treatment Outcome
8.
Clin Perinatol ; 33(2): 411-79, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16765732

ABSTRACT

This article is designed to be a basic introduction to neurometabolic diseases (ie, inheritable inborn errors of metabolism, genetic disorders of developmental neural topography, and degenerative disorders of neural function) that present in the neonate. It is intended to assist those who provide primary care for newborns to help them recognize signs and symptoms that signify neurometabolic disease; to teach how and when to initiate a neurometabolic diagnostic sequence; and to help neurologists and pediatricians interface with geneticists and metabolists. This article is intended to inform general newborn care practitioners, not metabolists. Therefore, pathways and concepts are presented in a simplified manner for deliberate educational purposes.


Subject(s)
Brain Diseases, Metabolic, Inborn , Brain Diseases, Metabolic, Inborn/diagnosis , Brain Diseases, Metabolic, Inborn/therapy , Diagnosis, Differential , Humans , Infant, Newborn , Neonatal Screening
9.
Brain Res Brain Res Rev ; 50(1): 169-83, 2005 Dec 01.
Article in English | MEDLINE | ID: mdl-16043226

ABSTRACT

Because the piglet is frequently used as a model for developmental disorders of the medullary serotonergic (5-HT) system in the human infant, this review compares the topography and developmental profile of selected 5-HT markers between humans in the first year of life and piglets in the first 60 days of life. The distribution of tryptophan hydroxylase-immunoreactive 5-HT neurons in the human infant medulla is very similar, but not identical, to that in the piglet. One notable difference is the presence of compact clusters of 5-HT neurons at the ventral surface of the piglet medulla. While it lacks these distinctive clusters, the human infant medulla contains potentially homologous 5-HT neurons scattered along the ventral surface embedded in the arcuate nucleus. Each species shows evidence of age-related changes in the 5-HT system, but the changes are different in nature; in the human infant, statistically significant age-related changes are observed in the proportional distribution of medullary 5-HT cells, while in the piglet, statistically significant age-related changes are observed in the levels of 5-HT receptor binding in certain medullary nuclei. Analyses of 5-HT receptor binding profiles in selected nuclei in the two species suggest that the equivalent postnatal ages for 5-HT development in piglets and human infants are, respectively, 4 days and 1 month, 12 days and 4 months, 30 days and 6 months, and 60 days and 12 months. Collectively, when certain species differences are considered, these data support the use of the piglet as a model for the human infant medullary 5-HT system.


Subject(s)
Developmental Disabilities/pathology , Medulla Oblongata , Neurons/metabolism , Serotonin/metabolism , Animals , Animals, Newborn , Child , Child, Preschool , Developmental Disabilities/metabolism , Disease Models, Animal , Humans , Medulla Oblongata/growth & development , Medulla Oblongata/metabolism , Medulla Oblongata/pathology , Neurons/pathology , Swine
10.
Mov Disord ; 19(10): 1256-8, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15389992

ABSTRACT

Amantadine suppressed severe levodopa-induced choreic dyskinesia, which developed at initiation of levodopa therapy, in two siblings manifesting dystonia with motor delay phenotype of GTP cyclohydrolase I deficiency caused by compound heterozygous GCH1 mutations. Our finding suggests a beneficial effect of amantadine on this type of dyskinesia frequently observed in relatively severe dopamine-deficient metabolic disorders.


Subject(s)
Amantadine/therapeutic use , Antiparkinson Agents/adverse effects , Antiparkinson Agents/therapeutic use , Dopamine Agents/therapeutic use , Dyskinesia, Drug-Induced/drug therapy , Dyskinesia, Drug-Induced/etiology , GTP Cyclohydrolase/genetics , Levodopa/adverse effects , Parkinson Disease/drug therapy , Parkinson Disease/genetics , Point Mutation/genetics , Child , Chorea/complications , Chorea/drug therapy , Heterozygote , Humans , Male , Pedigree , Phenotype
11.
Auton Neurosci ; 110(2): 65-80, 2004 Feb 27.
Article in English | MEDLINE | ID: mdl-15046730

ABSTRACT

The anatomy of the 5-HT system in the medulla oblongata is well defined in several vertebrate species, but not in the piglet. A detailed map and developmental profile of this system is particularly important in the piglet because this species increasingly is used as a model for physiological studies of medullary homeostatic control and its disorders in human infancy, especially the sudden infant death syndrome. Tryptophan hydroxylase immunohistochemistry was used to identify 5-HT cells and map their distribution in the medullae of piglets between postnatal days 4 and 30, the putative comparable period to early human infancy. Tritiated (3H)-lysergic acid diethylamide (LSD) binding to 5-HT1A-D and 5-HT2 receptors and 3H-8-hydroxy-2-[di-N-propylamine]tetralin (8-OH-DPAT) binding to 5-HT1A receptors were used to quantify and map the distribution of these serotonin receptors between 4 and 60 postnatal days. The distribution of 5-HT cells was similar to that observed in other vertebrate species, with cell bodies in and lateral to the caudal raphé. Tritiated-LSD and 3H-8-OH-DPAT binding both showed significant age-related changes in select raphé and extra-raphé subnuclei. Taken together, these findings suggest that while the medullary 5-HT cells are topographically in place at birth in the piglet, changes in 5-HT neurotransmission take place during the first 30 days of life, as reflected by changes in patterns of receptor binding. Therefore, the first 30 days of life represent a critical period in the development of the 5-HT system and the homeostatic functions it mediates.


Subject(s)
Medulla Oblongata/cytology , Medulla Oblongata/growth & development , Raphe Nuclei/cytology , Raphe Nuclei/growth & development , Serotonin/metabolism , Sus scrofa/anatomy & histology , 8-Hydroxy-2-(di-n-propylamino)tetralin/metabolism , 8-Hydroxy-2-(di-n-propylamino)tetralin/pharmacokinetics , Aging/metabolism , Animals , Animals, Newborn , Binding, Competitive/drug effects , Binding, Competitive/physiology , Blood Vessels/innervation , Cell Differentiation/physiology , Cell Size/physiology , Dendrites/metabolism , Dendrites/ultrastructure , Immunohistochemistry , Lysergic Acid Diethylamide/metabolism , Lysergic Acid Diethylamide/pharmacokinetics , Medulla Oblongata/metabolism , Neurons/cytology , Neurons/metabolism , Radioligand Assay , Raphe Nuclei/metabolism , Receptors, Serotonin, 5-HT1/metabolism , Receptors, Serotonin, 5-HT2/metabolism , Sus scrofa/growth & development , Synaptic Transmission/physiology , Tryptophan Hydroxylase/metabolism
12.
Exp Physiol ; 88(4): 509-15, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12861338

ABSTRACT

We evaluated the hypothesis that a 'central oxygen detector' in the brainstem is necessary for depressions of ventilatory activity to be manifested in the newborn. Decerebrate piglets, ventilated with 100 % O(2), were studied following neuromuscular blockade. The vagi and carotid sinus nerves were sectioned bilaterally in order to remove the influence of the peripheral chemoreceptors. Activity of the phrenic nerve was recorded as the index of the central respiratory rhythm. This activity declined and, in some preparations, ceased upon ventilation with air or a hypoxic gas, at either normocapnia or hypercapnia. The degree of depression in hypercapnic hypoxia was greatest in the youngest piglets. Following a medial section of the brainstem, extending to the caudal pons, the depression was reduced. In some preparations, a similar reduction followed the placement of radiofrequency lesions in the caudal ventromedial pons. We conclude that a region of the caudal mesencephalon or pons is necessary for the manifestation of depressions of ventilatory activity in the newborn pig.


Subject(s)
Brain Stem/physiopathology , Hypoxia/physiopathology , Respiratory Insufficiency/physiopathology , Respiratory Mechanics/physiology , Animals , Animals, Newborn , Brain Stem/pathology , Carbon Dioxide/blood , Female , Male , Phrenic Nerve/physiology , Swine
13.
J Appl Physiol (1985) ; 94(5): 1883-95, 2003 May.
Article in English | MEDLINE | ID: mdl-12679348

ABSTRACT

We tested the hypothesis that inhibition of neurons within the rostral ventral medulla (RVM) would prolong the laryngeal chemoreflex (LCR), a putative stimulus in the sudden infant death syndrome (SIDS). We studied the LCR in 19 piglets, age 3-16 days, by injecting 0.05 ml of saline or water into the larynx during wakefulness, non-rapid eye movement (NREM) sleep, and REM sleep, before and after 1 or 10 mM muscimol dialysis in the RVM. Muscimol prolonged the LCR (P < 0.05), and the prolongation was greater when the LCR was stimulated with water compared with saline (P < 0.02). The LCR was longer during NREM sleep than during wakefulness and longest during REM sleep (REM compared with wakefulness). Muscimol had no effect on the likelihood of arousal from sleep after LCR stimulation. We conclude that the RVM provides a tonic facilitatory drive to ventilation that limits the duration of the LCR, and loss of this drive may contribute to the SIDS when combined with stimuli that inhibit respiration.


Subject(s)
Larynx/drug effects , Medulla Oblongata/drug effects , Reflex/drug effects , Sudden Infant Death/pathology , Animals , Animals, Newborn , Arousal/drug effects , Arousal/physiology , Blood Pressure/drug effects , Blood Pressure/physiology , GABA Agonists/pharmacology , Humans , Infant , Microdialysis , Muscimol/pharmacology , Oxygen Consumption/drug effects , Polysomnography/drug effects , Respiratory Mechanics/drug effects , Sleep/physiology , Sleep, REM/physiology , Stereotaxic Techniques , Swine
14.
Pediatr Neurol ; 26(3): 201-4, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11955927

ABSTRACT

United States legislatures are debating whether to use tandem mass spectrometry to expand the roster of inherited disorders tested in newborn screening programs. The debate is hampered because published financial data comparing charges associated with late vs early diagnosis are not readily available. We provide pilot financial data comparing late diagnosis vs presumptive diagnosis and early management taken from consecutive patients with propionic acidemia diagnosed from 1995-1998 in New Hampshire. We extrapolated from these data and the incidence of treatable inborn errors of metabolism to estimate the projected yearly savings of critical care charges if expanded newborn screening were instituted. We conclude that institution of expanded screening will bring diminished morbidity and large savings in yearly chronic care and critical care charges.


Subject(s)
Amino Acid Metabolism, Inborn Errors/diagnosis , Amino Acid Metabolism, Inborn Errors/economics , Mass Spectrometry/economics , Neonatal Screening/economics , Propionates/blood , Amino Acid Metabolism, Inborn Errors/blood , Amino Acid Metabolism, Inborn Errors/therapy , Child, Preschool , Health Care Costs , Humans , Incidence , Infant , Infant, Newborn , Mass Spectrometry/methods , Metabolism, Inborn Errors/diagnosis , Metabolism, Inborn Errors/economics , Neonatal Screening/methods , New Hampshire/epidemiology , Pilot Projects , Time Factors
15.
Pediatr Neurol ; 26(3): 239-42, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11955936

ABSTRACT

Leigh syndrome is a heterogenous neurologic disease characterized by seizures, developmental delay, muscle weakness, respiratory abnormalities, optic abnormalities, including atrophy and ophthalmoplegia, and progressive cranial nerve degeneration with early onset in infants and children. Diagnosis can be confirmed by characteristic pathologic findings of necrosis in the basal ganglia, thalamus, and brainstem. Severe dysfunction of mitochondrial energy metabolism is generally present and involved in the etiology of this degenerative central nervous system disease. At the molecular level, a number of point mutations have been located in mitochondrial DNA genes, including ATPase6 and tRNA(Lys) genes, and in nuclear genes encoding subunits of oxidative enzymes, such as pyruvate dehydrogenase. Biochemically these mutations are responsible for enzymatic defects in either respiratory complexes (I, IV, or V) or pyruvate dehydrogenase. We describe here the first case of Leigh syndrome with marked depletion of mitochondrial DNA levels in skeletal muscle and abnormal activities in skeletal muscle of mitochondrial respiratory complexes I, III, IV, and V.


Subject(s)
DNA, Mitochondrial/metabolism , Leigh Disease/genetics , Brain/pathology , Electron Transport Complex I , Electron Transport Complex III/metabolism , Humans , Infant, Newborn , Leigh Disease/diagnosis , Leigh Disease/metabolism , Leigh Disease/pathology , Magnetic Resonance Imaging , Male , Mitochondria, Muscle/enzymology , Muscle, Skeletal/metabolism , NADH, NADPH Oxidoreductases/metabolism
16.
J Child Neurol ; 17(10): 759-65, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12546431

ABSTRACT

Cardiomyopathy and neuromuscular abnormalities may simultaneously coexist and present with defects in mitochondrial DNA and bioenergetic function. We sought to evaluate the relationship between clinical and mitochondrial phenotypes in 28 young patients with both cardiomyopathy and neurologic disorders including seizures, dystonia, ophthalmoplegia, Kearns-Sayre syndrome, Leigh disease, and Friedreich's ataxia. All tissues examined displayed marked defects in respiratory complex activities. Five patients had abundant large-scale mitochondrial DNA deletions and one patient displayed a pathogenic point mutation previously reported with mitochondrial cytopathy. In this cohort, patients with hypertrophic cardiomyopathy displayed a higher incidence of complex I defects, fewer DNA deletions and mitochondrial structural abnormalities and were less often associated with developmental delay phenotype compared with patients with dilated cardiomyopathy. Although structural abnormalities are present in a subset of patients, evaluation of respiratory enzyme activity appears to be most informative whether tissues examined were derived from heart or skeletal muscle. Defects in mitochondrial DNA and bioenergetics are frequently present in children with cardiomyopathy presenting with a variety of neurologic abnormalities and are amenable to biochemical and molecular analysis.


Subject(s)
Cardiomyopathies/genetics , Cardiomyopathies/pathology , DNA, Mitochondrial , Mitochondria/genetics , Mitochondria/pathology , Adolescent , Cardiomyopathies/physiopathology , Child , Child, Preschool , Dystonia/pathology , Electron Transport Complex I , Female , Friedreich Ataxia/pathology , Gene Deletion , Humans , Infant , Infant, Newborn , Kearns-Sayre Syndrome/pathology , Leigh Disease/pathology , Male , Mitochondrial Myopathies/genetics , Mitochondrial Myopathies/pathology , Muscle, Skeletal/pathology , Mutation , Myocardium/pathology , NADH, NADPH Oxidoreductases/metabolism , Neuromuscular Diseases/pathology , Ophthalmoplegia/pathology , Phenotype , Seizures/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...